China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | 1.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | 1.53% | |||
| Cost of Revenue | -0.48% | 2.71% | |||
| Gross Profit | -0.48% | -4.54% | |||
| SG&A Expenses | -0.48% | 15.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.48% | 13.53% | |||
| Total Operating Expenses | -0.48% | 4.07% | |||
| Operating Income | -0.48% | -39.42% | |||
| Income Before Tax | -0.48% | -44.24% | |||
| Income Tax Expenses | -0.48% | -31.39% | |||
| Earnings from Continuing Operations | -0.48% | -47.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.48% | 27.07% | |||
| Net Income | -0.48% | -71.03% | |||
| EBIT | -0.48% | -39.42% | |||
| EBITDA | -0.48% | -32.62% | |||
| EPS Basic | -1.23% | -71.68% | |||
| Normalized Basic EPS | 0.00% | -40.63% | |||
| EPS Diluted | -1.23% | -71.38% | |||
| Normalized Diluted EPS | 0.00% | -40.63% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | -36.84% | |||
| Payout Ratio | 0.00% | -- | |||